Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Prestige Consumer HealthcarePBH -2.24%69 Interest Coverage is 3.77 as of Jun. 2026, which is 13% below its 10-year median of 4.34. GuruFocus rates PBH with a GF Score™ of 69/100 and a GF Value™ of $70.51 (Modestly Undervalued). The stock has 2 warning signs investors should review. Among 684 Drug Manufacturers companies, Prestige Consumer Healthcare ranks worse than 65.64% on this metric.
Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's
Operating Income
by its Interest Expense. Prestige Consumer Healthcare's
Operating Income
for the
three
months ended in Jun. 2026 was $53 Mil. Prestige Consumer Healthcare's Interest Expense for the
three
months ended in Jun. 2026 was $-14 Mil.
Prestige Consumer Healthcare's interest coverage for the quarter that ended in Jun. 2026 was 3.77.
The higher the ratio, the stronger the company's financial strength is.
The historical rank and industry rank for Prestige Consumer Healthcare's Interest Coverage or its related term are showing as below:
PBH'
s Interest Coverage Range Over the Past 10 Years
Min: 0.63 Med: 4.34 Max: 7.33
Current: 6.3
PBH's Interest Coverage is ranked worse than 65.64% of 684
companies
in the Drug Manufacturers industry
Industry Median: 13.55
vs PBH: 6.30
Ben Graham requires that a company has a minimum interest coverage of 5 with the companies he invested. If the interest coverage is less than 2, the company is burdened by debt. Any business slow or recession may drag the company into a situation where it cannot pay the interest on its debt.
Interest Coverage is an important factor when GuruFocus ranks a company's overage Financial Strength .
Prestige Consumer Healthcare Interest Coverage Related Terms
Prestige Consumer Healthcare Interest Coverage Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Note: For Interest Coverage, "No debt" indicates no long-term debt. An indication of "No Debt" does not necessarily mean that the company has no long-term debt obligations; it could be due to missing data in the quarterly or annual report. Use caution when interpreting this information.
PBH vs BCRX, AMLX, SUPN: Interest Coverage Comparison
For the Drug Manufacturers - Specialty & Generic subindustry, Prestige Consumer Healthcare's Interest Coverage, along with its competitors' market caps and Interest Coverage data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Prestige Consumer Healthcare Interest Coverage vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Prestige Consumer Healthcare's Interest Coverage distribution charts can be found below:
* The bar in red indicates where Prestige Consumer Healthcare's Interest Coverage falls into.
Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income (EBIT) by its Interest Expense:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Prestige Consumer Healthcare (PBH) has a Interest Coverage of 3.77 as of Jun. 2026. Interest Coverage measures a company's capability to pay interest expenses on its debt. View historical data on Prestige Consumer Healthcare and its competitors. This is 13% below median its historical median of 4.34. Over the past decade, Prestige Consumer Healthcare's Interest Coverage has ranged from 0.63 to 7.33. According to the industry distribution chart, Prestige Consumer Healthcare ranks #449 out of 684 companies in the Drug Manufacturers industry, placing it in the top 65.6%.
Is Prestige Consumer Healthcare's Interest Coverage too high?
Prestige Consumer Healthcare's current Interest Coverage of 3.77 is 13% below median its 10-year median of 4.34. Over the past 10 years, this metric has ranged from a low of 0.63 to a high of 7.33. The Drug Manufacturers industry median Interest Coverage is 13.55. Prestige Consumer Healthcare's value of 3.77 is 72.2% below this industry median. Based on the distribution chart, Prestige Consumer Healthcare ranks #449 out of 684 companies in the Drug Manufacturers industry, which is below the industry midpoint. Overall, Prestige Consumer Healthcare has a GF Score™ of 69/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Prestige Consumer Healthcare's Interest Coverage compare to BCRX and AMLX?
According to the Drug Manufacturers industry distribution chart, Prestige Consumer Healthcare ranks #449 out of 684 companies for Interest Coverage. This places Prestige Consumer Healthcare in the lower half of its industry. The industry median Interest Coverage is 13.55. Prestige Consumer Healthcare's value of 3.77 is 72.2% below this benchmark. Historically, Prestige Consumer Healthcare's own Interest Coverage has ranged from 0.63 to 7.33 over the past decade. While the company's 10-year median is 4.34 vs. the industry median of 13.55, Prestige Consumer Healthcare has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Interest Coverage for a Drug Manufacturers company?
The median Interest Coverage among Drug Manufacturers companies is 13.55, based on 684 companies in the industry. Companies in the top quartile (top 25%) have a Interest Coverage significantly above this median, while those in the bottom quartile fall well below. However, Interest Coverage should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Prestige Consumer Healthcare's current Interest Coverage of 3.77 is 72.2% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Interest Coverage mean?
A high Interest Coverage can signal that a stock is expensive relative to its fundamentals. Interest Coverage measures a company's capability to pay interest expenses on its debt. View historical data on Prestige Consumer Healthcare and its competitors. For the Drug Manufacturers industry, the median Interest Coverage is 13.55 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Prestige Consumer Healthcare's current Interest Coverage is 3.77, which is 13% below median its own 10-year median of 4.34. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Prestige Consumer Healthcare stock overvalued right now?
Based on GuruFocus' analysis, Prestige Consumer Healthcare (PBH) is currently considered Modestly Undervalued. The stock's GF Value™ is $70.51, compared to a current price of $50.52 — trading 28.4% below its estimated fair value. The current Interest Coverage is 3.77, which is 13% below median its 10-year median of 4.34 and 72.2% below the Drug Manufacturers industry median of 13.55. Prestige Consumer Healthcare's overall GF Score™ is 69/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Interest Coverage calculated?
Interest Coverage is calculated from a company's financial statements. For Prestige Consumer Healthcare (PBH), the current Interest Coverage is 3.77 as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Prestige Consumer Healthcare (PBH) Overvalued in 2026?
Based on GuruFocus' analysis, Prestige Consumer Healthcare stock appears to be undervalued.
The current stock price of $50.52 is trading 28.4% below its estimated GF Value™ of $70.51.
GuruFocus considers Prestige Consumer Healthcare to be Modestly Undervalued.
Key valuation signals for PBH:
Interest Coverage: 3.77 (13% below median its 10-year median of 4.34)
GF Value™: $70.51 vs. price of $50.52 (28.4% below fair value)
Industry Position: 72.2% below the Drug Manufacturers median (#449 of 684)
No single metric tells the full story. See the PBH stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Prestige Consumer Healthcare is one of the largest pure-play over-the-counter healthcare providers. It has a diverse portfolio composed of leading brands in niche consumer health categories. Prestige's key brands include Clear Eyes (redness relief), Dramamine (motion sickness relief), Monistat (vaginal anti-fungal), and Summer's Eve (feminine hygiene), and many of its brands enjoy category leadership and recommendations from medical professionals. The firm mainly plays in North America where it generates roughly 85% of its total revenue, and the remaining sales come from Australia, New Zealand, and certain Asian markets.
69GF Score
Get the complete analysis for PBH
Interest Coverage is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
PBH has been successfully added to your 
